I don’t agree in a buy-out. You give up so much potential. We as investors don’t need the help and we will cross that finish line. For me... that is happening as we speak behind the scenes as we don’t know what is happening and Cytodyn can’t divulge everything if the government is somehow involved behind the scenes with an approval. Myself I believe they are aware of where we are. Take the Medicare and Medicaid billing numbers by name written in for Cytodyn. This is only a little smoke but has some creative thinking possibly going on that we don’t know about.

At this point we don’t need a buy out to further our process. We are on the cusp of greatness and it would only reduce our investment to share the potential with another pharmaceutical company by selling out. I am not a proponent of a fast nickel when a slow dime is just around the corner. I don’t believe it’s going to be a slow dime either is going to be a wind fall of dimes... giving up a potential of something amazing like Vyrologix is like giving up an early stock like Microsoft or Apple and taking a few thousand dollars for what could be millions of dollars.

To me... I look at inflammation as the single worst symptom of most diseases and what does Leronlimab do? Reduce inflammation. How does this happen? It stops the inflammation by stopping the immune response. So we have an amazing drug that regulates the immune system and stops the immune system from attacking the victim and does this all with unmatched safety. When you look at the action of this little molecule. You have to see that this method of action could very well work for many diseases. Stopping them cold in their tracks. With all this potential I will wait for the best return an investor can hope for. The new Amazon type investment is Cytodyn. 3-5 years from now... we will all be laughing at the thought of what if... what if we would of sold out or been bought out. When we are traveling the world with all the money from our Vyrologix investment that helped Vyrologix help to make the world become a Safe place again. Especially if we become a vaccine booster to lengthen the time of vaccine that might only be good for 6 months or so. Covid could be huge for us if that happen. But even if it doesn’t. There are many ways looking forward that you can see this drug being a blockbuster for not just one indication. But for many blockbuster indications. Call me greedy... I don’t want to share that with other big pharmaceutical companies when we don’t have to. We are on the cusp of something great. But that’s just my opinion. You others can have your opinions. It wouldn’t take away from my beliefs and I will hold Vyrologix for that 3-5 years and still keep a large share invested forever.